» Articles » PMID: 18200434

Co-transmission of Conduct Problems with Attention-deficit/hyperactivity Disorder: Familial Evidence for a Distinct Disorder

Abstract

Common disorders of childhood and adolescence are attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD) and conduct disorder (CD). For one to two cases in three diagnosed with ADHD the disorders may be comorbid. However, whether comorbid conduct problems (CP) represents a separate disorder or a severe form of ADHD remains controversial. We investigated familial recurrence patterns of the pure or comorbid condition in families with at least two children and one definite case of DSM-IV ADHDct (combined-type) as part of the International Multicentre ADHD Genetics Study (IMAGE). Using case diagnoses (PACS, parental account) and symptom ratings (Parent/Teacher Strengths and Difficulties [SDQ], and Conners Questionnaires [CPTRS]) we studied 1009 cases (241 with ADHDonly and 768 with ADHD + CP), and their 1591 siblings. CP was defined as > or =4 on the SDQ conduct-subscale, and T > or = 65, on Conners' oppositional-score. Multinomial logistic regression was used to ascertain recurrence risks of the pure and comorbid conditions in the siblings as predicted by the status of the cases. There was a higher relative risk to develop ADHD + CP for siblings of cases with ADHD + CP (RRR = 4.9; 95%CI: 2.59-9.41); p < 0.001) than with ADHDonly. Rates of ADHDonly in siblings of cases with ADHD + CP were lower but significant (RRR = 2.9; 95%CI: 1.6-5.3, p < 0.001). Children with ADHD + CP scored higher on the Conners ADHDct symptom-scales than those with ADHDonly. Our finding that ADHD + CP can represent a familial distinct subtype possibly with a distinct genetic etiology is consistent with a high risk for cosegregation. Further, ADHD + CP can be a more severe disorder than ADHDonly with symptoms stable from childhood through adolescence. The findings provide partial support for the ICD-10 distinction between hyperkinetic disorder (F90.0) and hyperkinetic conduct disorder (F90.1).

Citing Articles

Early risk factors for conduct problem trajectories from childhood to adolescence: the 2004 Pelotas (BRAZIL) Birth Cohort.

Martins-Silva T, Bauer A, Matijasevich A, Munhoz T, Barros A, Santos I Eur Child Adolesc Psychiatry. 2023; 33(3):881-895.

PMID: 37097345 PMC: 10126565. DOI: 10.1007/s00787-023-02178-9.


Correlation research of susceptibility single nucleotide polymorphisms and the severity of clinical symptoms in attention deficit hyperactivity disorder.

Xu Y, Lin S, Tao J, Liu X, Zhou R, Chen S Front Psychiatry. 2022; 13:1003542.

PMID: 36213906 PMC: 9538111. DOI: 10.3389/fpsyt.2022.1003542.


Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?.

Balogh L, Pulay A, Rethelyi J Front Psychol. 2022; 13:751041.

PMID: 35350735 PMC: 8957927. DOI: 10.3389/fpsyg.2022.751041.


Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder.

Demontis D, Walters R, Rajagopal V, Waldman I, Grove J, Als T Nat Commun. 2021; 12(1):576.

PMID: 33495439 PMC: 7835232. DOI: 10.1038/s41467-020-20443-2.


Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD.

Evangelisti M, De Rossi P, Rabasco J, Donfrancesco R, Lionetto L, Capi M Eur Child Adolesc Psychiatry. 2017; 26(12):1433-1441.

PMID: 28527020 DOI: 10.1007/s00787-017-1002-2.


References
1.
Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley S, McGough J . ADHD and comorbid disorders in relation to family environment and symptom severity. Eur Child Adolesc Psychiatry. 2007; 16(6):362-9. DOI: 10.1007/s00787-007-0607-2. View

2.
Faraone S, Sergeant J, Gillberg C, Biederman J . The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry. 2006; 2(2):104-13. PMC: 1525089. View

3.
Greene R, Biederman J, Zerwas S, Monuteaux M, Goring J, Faraone S . Psychiatric comorbidity, family dysfunction, and social impairment in referred youth with oppositional defiant disorder. Am J Psychiatry. 2002; 159(7):1214-24. DOI: 10.1176/appi.ajp.159.7.1214. View

4.
Nock M, Kazdin A, Hiripi E, Kessler R . Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication. Psychol Med. 2006; 36(5):699-710. PMC: 1925033. DOI: 10.1017/S0033291706007082. View

5.
Goodman R . The Strengths and Difficulties Questionnaire: a research note. J Child Psychol Psychiatry. 1997; 38(5):581-6. DOI: 10.1111/j.1469-7610.1997.tb01545.x. View